Posts tagged first-in-human colombia
PAVmed Selects Colombia for a First-in-Human Study on its PortIO™ Medical Device
PAVmed Selects Colombia for a First-in-Human Study on its PortIO™ Medical Device

PAVmed Inc. (Nasdaq:PAVM), is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. PAVmed has selected bioaccess.™ as its contract research organization (CRO) for a first-in-human clinical trial of its PortIO medical device. The clinical trial will be led by Dr. Jorge Humberto Ulloa —a leading vascular surgeon who trained at the Walter Reed Army Medical Center Washington DC— and will be conducted at Cirulaser Andes (“Cirulaser”) in Bogota, Colombia — a specialized vascular center affiliated with Hospital Universitario de la Fundación Santa Fé de Bogotá ("FSFB").

Read More
Clinical TrialsJulio G. Martinez-ClarkPAVmed, PortIO, Cirulaser Andes, Jorge Humberto Ulloa, first-in-human, first-in-human clinical trial in Colombia, first-in-human colombiaComment